Application of zero-profile 3D-printed artificial vertebral bodies for the treatment of cervical spondylotic myelopathy

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400089860

Enrollment

Unknown

Registered

2024-09-18

Start date

2023-02-20

Completion date

Unknown

Last updated

2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylotic myelopathy

Interventions

Zero-trace group:Application of zero-notch 3D-printed artificial vertebrae for ACCF surgery

Steel plate set:Application of steel plates plus 3D printed artificial vertebrae for ACCF.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Clinical symptoms and signs met the international diagnostic criteria for spinal cord cervical spondylosis, and there were typical symptoms of spinal cord compression such as progressive sensory, motor or sphincter dysfunction in the limbs; CT and MRI showed cervical spine degeneration and spinal cord compression; (2) the age of 18-70 years old; and (3) undergoing ACCF with a sub-total resection of a single vertebral body.

Exclusion criteria

Exclusion criteria: ? Diagnosis of osteoporosis (BMD T-value = -2.5) without systemic treatment; ? Presence of systemic or localized infection; ? History of previous cervical spine surgery; ? Loss of postoperative visits.

Design outcomes

Primary

Measure	Time frame
JOA;Interbody Fusion Time;Incidence of dysphagia;Prosthesis subsidence rate;	—

Secondary

Measure	Time frame
Surgical time;Complication rate;Intraoperative blood loss;Hospitalization expenses;	—

Countries

China

Contacts

Public ContactYuwei Li

Staff of Luohe Central Hospital

460910316@qq.com+86 139 4986 8369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026